Standard Document
First Edition
Clinical Chemistry and Toxicology

CLSI C37

Preparation and Validation of Commutable Frozen Human Serum Pools as Secondary Reference Materials for Cholesterol Measurement Procedures

CLSI C37 provides a detailed framework for selecting, processing, and validating commutable frozen human serum pools as secondary reference materials for serum cholesterol measurement. This guideline ensures consistency across multiple testing methods, supporting accurate calibration and standardization in cholesterol assays. It also includes evaluation protocols and a summary of pilot study results that validate the scientific basis of these procedures.

November 01, 1999
Gary L. Myers, PhD

{{FormatPrice(currentPrice)}}

Free

{{FormatPrice(nonMemberPrice)}} List Price
This is your member pricing.
Notify Me About New Editions
Abstract

Preparation and Validation of Commutable Frozen Human Serum Pools as Secondary Reference Materials for Cholesterol Measurement Procedures; Approved Guideline (C37-A) outlines procedures for selecting, processing, and combining donor units to prepare frozen serum pools which are commutable among multiple methods for serum cholesterol measurement. The guideline also addresses issues related to the evaluation of the pooled materials. The manufacture and evaluation of two levels of serum cholesterol pools prepared according to this guideline are described. The appendix includes a summary of the results from the pilot study conducted to evaluate the scientific basis of this guideline. This guideline will provide information to develop reference materials which can be useful to manufacturers of in vitro diagnostic (IVD) reagents, systems, and quality control products in establishment of calibration (or assigned values) for their products. Additionally, these reference materials can be beneficial to proficiency testing agencies, as well as end users in the clinical laboratory as tools to independently assess performance (and trueness) of procedures for the routine measurement of serum cholesterol.

Scope
These specifications are designed to enable laboratory scientists, in vitro diagnostic (IVD) manufacturers, proficiency testing providers, and suppliers of clinical laboratory reference materialsa to prepare frozen human serum pools which demonstrate minimal matrix effects, are commutable across different cholesterol measurement procedures, and, as such, are suitable for assessing the trueness of these procedures. These serum pools, when assigned target values by the definitive method and/or reference method of the National Reference System for Cholesterol (NRS/CHOL), may be used to properly calibrate and/or assess trueness of field methods for serum cholesterol measurement, and provide an alternative method to split-sample comparisons with human specimens for establishing traceability of calibration of field methods to the NRS/CHOL. This document provides guidance for collecting and processing raw materials to manufacture frozen serum pools and for performing quality assurance of the final product. As part of the guideline development, two frozen human serum pools using a large number of selected individual donor units of "off-the-clot" serum were prepared and characterized. The performance of the pools was assessed in terms of the degree of commutability (observed response versus predicted response) relative to the individual sera which comprised the pools.
Product Details
C37AE
1-56238-392-2
52
Additional Details

The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus standard for use in satisfying a regulatory requirement.

This document is available in electronic format only.

This archived document is no longer being reviewed through the CLSI Consensus Document Development Process. However, this document is technically valid and because of its value to the laboratory community, it is being retained in CLSI’s library.

Authors
Gary L. Myers, Ph.D., Chairholder
John H. Eckfeldt, M.D., Ph.D.
Neil Greenberg, Ph.D.
Jacob B. Levine, M.B.A.
W. Gregory Miller, Ph.D.
Donald A. Wiebe, Ph.D.
Abstract

Preparation and Validation of Commutable Frozen Human Serum Pools as Secondary Reference Materials for Cholesterol Measurement Procedures; Approved Guideline (C37-A) outlines procedures for selecting, processing, and combining donor units to prepare frozen serum pools which are commutable among multiple methods for serum cholesterol measurement. The guideline also addresses issues related to the evaluation of the pooled materials. The manufacture and evaluation of two levels of serum cholesterol pools prepared according to this guideline are described. The appendix includes a summary of the results from the pilot study conducted to evaluate the scientific basis of this guideline. This guideline will provide information to develop reference materials which can be useful to manufacturers of in vitro diagnostic (IVD) reagents, systems, and quality control products in establishment of calibration (or assigned values) for their products. Additionally, these reference materials can be beneficial to proficiency testing agencies, as well as end users in the clinical laboratory as tools to independently assess performance (and trueness) of procedures for the routine measurement of serum cholesterol.

Scope
These specifications are designed to enable laboratory scientists, in vitro diagnostic (IVD) manufacturers, proficiency testing providers, and suppliers of clinical laboratory reference materialsa to prepare frozen human serum pools which demonstrate minimal matrix effects, are commutable across different cholesterol measurement procedures, and, as such, are suitable for assessing the trueness of these procedures. These serum pools, when assigned target values by the definitive method and/or reference method of the National Reference System for Cholesterol (NRS/CHOL), may be used to properly calibrate and/or assess trueness of field methods for serum cholesterol measurement, and provide an alternative method to split-sample comparisons with human specimens for establishing traceability of calibration of field methods to the NRS/CHOL. This document provides guidance for collecting and processing raw materials to manufacture frozen serum pools and for performing quality assurance of the final product. As part of the guideline development, two frozen human serum pools using a large number of selected individual donor units of "off-the-clot" serum were prepared and characterized. The performance of the pools was assessed in terms of the degree of commutability (observed response versus predicted response) relative to the individual sera which comprised the pools.
Additional Details

The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus standard for use in satisfying a regulatory requirement.

This document is available in electronic format only.

This archived document is no longer being reviewed through the CLSI Consensus Document Development Process. However, this document is technically valid and because of its value to the laboratory community, it is being retained in CLSI’s library.

Authors
Gary L. Myers, Ph.D., Chairholder
John H. Eckfeldt, M.D., Ph.D.
Neil Greenberg, Ph.D.
Jacob B. Levine, M.B.A.
W. Gregory Miller, Ph.D.
Donald A. Wiebe, Ph.D.